A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice-Reference-Cited by-同舟云学术

A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice

Published:2019-05-31 Issue:1 Volume:20 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Vijapurapu Ravi^ORCID,Kozor Rebecca,Hughes Derralynn A.,Woolfson Peter,Jovanovic Ana,Deegan Patrick,Rusk Rosemary,Figtree Gemma A.,Tchan Michel,Whalley David,Kotecha Dipak,Leyva Francisco,Moon James,Geberhiwot Tarekegn,Steeds Richard P.

Funder

Genzyme

Shire

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-019-3425-1.pdf

Reference35 articles.

1. Van der Tol L, Smid BE, Poorthuis BJHM, Biegstraaten M, Deprez RHL, Linthorst GE, et al. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet. 2014;51:1–9.

2. Adalsteinsdottir B, Palsson R, Desnick RJ, Gardarsdottir M, Teekakirikul P, Maron M, et al. Fabry disease in families with hypertrophic cardiomyopathy: clinical manifestations in classic and later-onset phenotypes. Circ Cardiovasc Genet. 2017;10:1–10.